Moderna's dual Covid-flu vaccine poised for EMA approval on positive CHMP take [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
marketing authorisation to Moderna's combination Covid-19 and influenza vaccine, mCombriax (mRNA-1083). The Committee for Medicinal Products for Human Use's (CHMP) opinion is based on the results of a pivotal Phase III study (NCT06097273), where mCombriax prompted a significantly higher immune response against Covid-19 and three flu strains than a combination of Sanofi's influenza jab, Fluzone high-dose quadrivalent (Fluzone HD) and Moderna's Covid-19 vaccine, Spikevax. The EMA will now make the final decision on whether to give mCombriax the greenlight, which could become the first ever combination Covid-flu vaccine to reach the global market. According to Moderna's CEO, Stéphane Bancel, combination vaccines hold the potential to “simplify vaccination and support improved health outcomes”. The CHMP's call will be welcome news for Moderna, which has encountered several hurdles while seeking US approval for its late-stage pipeline vaccines. Most recently, the US Food and Drug Adm
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Amgen Faces Rocatinlimab Halt And Rethinks Pipeline And Capital Priorities [Yahoo! Finance]Yahoo! Finance
- Podcast: Sanofi's head of clinical supply chain operations on evolving the clinical trial supply model [Yahoo! Finance]Yahoo! Finance
- Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Press Release: Sanofi's Board of Directors proposes the appointment of Christel Heydemann as an independent director [Yahoo! Finance]Yahoo! Finance
- Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent directorGlobeNewswire
SNY
Sec Filings
- 3/4/26 - Form 6-K
- 3/3/26 - Form 6-K
- 2/23/26 - Form 6-K
- SNY's page on the SEC website